The CDD Department of Research and Innovation
is a clinical research group, working in conjunction
with private industry – largely pharmaceutical or biotechnology
companies – and independently to conduct clinical trials.
Clinical research is conducted for development of new and
existing pharmaceutical products, as well as medical devices.
All clinical research conducted at CDD
is reviewed by a Human Research Ethics Committee. The
HREC functions in accordance with the National Statement
on Ethical Conduct in Research involving Humans as issued
by the National Health and Medical Research Council (NHMRC)
in accordance with the NHMRC Act, 2007 (Cth), ICH / TGA
Good Clinical practice (GCP) guidelines (2000), and the Declaration
of Helsinki (2004).
The Department of Research and Innovation
is contracted as a clinical research site for many international
pharmaceutical sponsored studies in the field of gastroenterology.
CDD has worked with many large international Contract
Research Organisation’s (CRO’s) to provide a high professional
and clinical standard of research. Internal clinical studies
designed and directed by Prof. Thomas Borody are conducted
to develop treatments and provide new therapies based
on his experience in clinical practice. CDD through its
Department of Research and Innovation can therefore provide
new and effective therapies to patients that would otherwise
be unavailable to the wider community.
Back
Home | Back to Top
